References

  1. World Health Organization. The global MDR-TB & XDR-TB response plan 2007-2008. 2007.

  2. World Health Organization. Treatment of tuberculosis: guidelines. World Health Organization. 2010.

  3. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010 Sep 9; 363(11): 1005-15. PubMed | Google Scholar

  4. Chan ED, Iseman MD. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis. 2008 Dec;21(6):587-95. PubMed | Google Scholar

  5. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010 Jan; 48(1): 229-37. PubMed | Google Scholar

  6. Maxmen A. Fighting the monster. Nature. 2010 Jul 15; 466(7304): S18-9. PubMed | Google Scholar

  7. World Health Organisation. Nigeria: Tuberculosis Country profile 2016. Geneva, Switzerland: World Health Organisation. December 2017. Accesed on 10 december 2017.

  8. Anek-vorapong R, Sinthuwattanawibool C, Podewils LJ, McCarthy K, Ngamlert K, Promsarin B et al. Validation of the GenoTypeŽ MTBDR plus assay for detection of MDR-TB in a public health laboratory in Thailand. BMC Infect Dis. 2010 May 20; 10: 123. Google Scholar

  9. Causse M, Ruiz P, Gutierrez J, Zerolo J, Casal M. Evaluation of new GenoTypeŽ MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2008 Dec; 12(12): 1456-60. Google Scholar

  10. Huang W-L, Chen H-Y, Kuo Y-M, Jou R. Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2009 Aug; 47(8): 2520-4. PubMed | Google Scholar

  11. Lacoma A, Garcia-Sierra N, Prat C, Ruiz-Manzano J, Haba L, Roses S et al. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol. 2008 Nov; 46(11): 3660-7. PubMed | Google Scholar

  12. El-Hajj HH, Marras SA, Tyagi S, Kramer FR, Alland D. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol. 2001 Nov; 39(11): 4131-7. PubMed | Google Scholar

  13. City populations worldwide. Bayelsa Population 2017. Accesed on 10 december 2017.

  14. Otu A, Umoh V, Habib A, Ameh S, Lawson L, Ansa V. Drug resistance among pulmonary tuberculosis patients in Calabar, Nigeria. Pulm Med. 2013; 2013: 235190. PubMed | Google Scholar

  15. Onyedum CC, Alobu I, Ukwaja KN. Prevalence of drug-resistant tuberculosis in Nigeria: a systematic review and meta-analysis. PLoS One. 2017 Jul 13; 12(7): e0180996. PubMed | Google Scholar